glp 1 as a pill Eli Lilly GLP-1 Foundayo approved for obesity This gentle GLP-1 pills are on the

Ashtary-Larky, D., Ravasi, A., Akbari-Polak, R., Bagheri, R., Dutheil, F., Wong, A., & Sahebkar, A

It ensures clinical decisions remain with licensed clinicians, not with the technology company

Additionally, on April 30, 2026, one of Novo Nordisks competitors completed phase three of a clinical trial of a drug that they hope will help people lose weight and reduce liver fat. The clinical trial involved people who have obesity or are overweight and have also been diagnosed with a specific type of liver disease

While this is an important consideration, there is no literature at this time to help delineate whether or not this is a significant enough factor to consider when compared to the aspiration risk that GLP-1 agonists provide